Cabozantinib with nivolumab for untreated advanced renal cell carcinoma

  • Technology appraisal guidance
  • TA964
  • Published: 
Download guidance (PDF)

Update information

May 2024: this guidance was updated to add the implementation section.

ISBN: 978-1-4731-5861-0